Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts

NCT04649541 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety

Interventions

DRUG: MRX-8
DRUG: Placebo

Sponsor

MicuRx

Collaborators

[object Object]
[object Object]